Siddharama Pawate - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Siddharama Pawate

Showing results (31-40 of 36) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 36 results.

JAMA Neurology|September 1, 2018

Definition and Consensus Diagnostic Criteria for Neurosarcoidosis: From the Neurosarcoidosis Consortium Consensus GroupBarney J Stern, Walter Royal, Jeffrey M Gelfand, et al.

Journal of Neurology|July 18, 2025

Rituximab in pathologically confirmed sarcoidosis affecting the central nervous system: a multi-center retrospective studySpencer K Hutto, Denis Balaban, Zachery Rohm, et al.

Neurology|October 15, 2017

Infliximab for the treatment of CNS sarcoidosis: A multi-institutional seriesJeffrey M Gelfand, Michael J Bradshaw, Barney J Stern, et al.

Neurology. Clinical Practice|May 1, 2018

Effectiveness of alternative dose fingolimod for multiple sclerosisErin E Longbrake, Daniel Kantor, Siddharama Pawate, et al.

Contemporary Clinical Trials|October 24, 2025

The TRaditional versus Early Aggressive Therapy for Multiple Sclerosis (TREAT-MS) trial: design and baseline characteristics of participantsEllen M Mowry, Peiqing Qian, William Meador, et al.

Neurology. Clinical Practice|January 20, 2025

Consensus Recommendations for the Management of Neurosarcoidosis: A Delphi Survey of Experts Across the United StatesGiovanna Sophia Manzano, James Eaton, Michael Levy, et al.

Pageof 4

Search research articles

Showing results (31-40 of 36) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 36 results.

JAMA Neurology|September 1, 2018

Definition and Consensus Diagnostic Criteria for Neurosarcoidosis: From the Neurosarcoidosis Consortium Consensus GroupBarney J Stern, Walter Royal, Jeffrey M Gelfand, et al.

Journal of Neurology|July 18, 2025

Rituximab in pathologically confirmed sarcoidosis affecting the central nervous system: a multi-center retrospective studySpencer K Hutto, Denis Balaban, Zachery Rohm, et al.

Neurology|October 15, 2017

Infliximab for the treatment of CNS sarcoidosis: A multi-institutional seriesJeffrey M Gelfand, Michael J Bradshaw, Barney J Stern, et al.

Neurology. Clinical Practice|May 1, 2018

Effectiveness of alternative dose fingolimod for multiple sclerosisErin E Longbrake, Daniel Kantor, Siddharama Pawate, et al.

Contemporary Clinical Trials|October 24, 2025

The TRaditional versus Early Aggressive Therapy for Multiple Sclerosis (TREAT-MS) trial: design and baseline characteristics of participantsEllen M Mowry, Peiqing Qian, William Meador, et al.

Neurology. Clinical Practice|January 20, 2025

Consensus Recommendations for the Management of Neurosarcoidosis: A Delphi Survey of Experts Across the United StatesGiovanna Sophia Manzano, James Eaton, Michael Levy, et al.

Pageof 4